The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome

Nephrology Dialysis Transplantation

Volumn 11, Issue 12, 1996, Pages 2498-2500

  Richardson, D ^a   Jones, C H ^a   Newstead, C G ^a   Will, E J ^a   Lodge, J P ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cyclosporin A; Haemolytic uraemic syndrome; Renal transplantation; Tacrolimus (FK506)

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE COURSE; DRUG BLOOD LEVEL; FEMALE; GRAFT REJECTION; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBUS;

EID: 0030468923     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027225     Document Type: Article

References (12)

1. Atkinson K, Biggs JC, Hayes J et al. Cyclosporin A associated nephropathy in the first 100 days after allogenic bone marrow transplantation: three distinct syndromes. Br J Haematol 1983; 54: 59-67
2. Bonser RS, Adu D, Franklin I, McMaster P. Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient. Lancet 1984; 2: 1337
3. Van Burren D, Van Burren CT, Flechner SM et al. De novo hemolytic uraemic syndrome in renal transplant recipients immunosuppressed with cyclosporin. Surgery 1985; 98: 54
4. Galli FC, Damon LE, Tomlanovich SJ et al. Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient. J Heart Lung Transplant 1993; 12: 440-444
5. Venkat KK, Tkach D, Kupin W et al. Reversal of cyclosporine-associated hemolytic uremic syndrome by plasma exchange with fresh frozen plasma replacement in renal transplant recipients. Transplant Proc 1991; 23: 1256-1257
6. Kaufman DB, Kaplan B, Kanwar YS, Abecassis M, Stuart FP. The successful use of Tacrolimus (FK 506) in a pancreas/kidney transplant recipient with recurrent hemolytic uremic syndrome. Transplantation 1994; 59: 1737-1739
7. Hochstetler LA, Flanigan MJ, Lager DJ. Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy. Am J Kidney Dis 1994; 23: 444-450
8. Buturovic J, Kandus A, Malovrh M, Bren A, Drinovec J. Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy. Transplant Proc 1990; 22: 1726-1727
9. Jordan ML, Shapiro R, Vivas CA et al. FK506 'rescue' for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994; 57: 8860-865
10. McCauley J, Bronsther O, Fung J, Todo S. Starzl TE. Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK 506. Lancet 1989; 2: 1516
11. Abdalla AH, al Sulaiman MH, Khader A. FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient. Transplant Int 1994; 7: 382-384
12. Schmidt RJ, Venkat KK, Dumler F. Hemolytic uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. Transplant Proc 1991; 23: 3156-3157